Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-26

Clinical Trial Update: Prevention of Acute Kidney Injury by Erythropoietin in Thoracic Aorta Surgery With Hypothermic Cardiac Arrest [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update examining whether erythropoietin can prevent acute kidney injury in patients undergoing thoracic aorta dissection surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Yonsei University | Conditions: Dissection of Thoracic Aorta | Phase 4 | Status: COMPLETED | Results posted: 2013-09-26